23
Differentiation of Peri- Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging Dr Nader Zakhari and Dr Thanh Nguyen The Ottawa Hospital EE-07

Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Embed Size (px)

Citation preview

Page 1: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

 Differentiation of Peri-Ictal Pseudoprogression from Tumor

Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted

and Perfusion Imaging

Dr Nader Zakhari and Dr Thanh Nguyen

The Ottawa Hospital

EE-07

Page 2: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Disclosure

Dr Thanh Binh Nguyen has received an investigator-initiated research grant from Bayer Pharmaceutical

Page 3: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Purpose

Peri-ictal pseudoprogression “PIPG”

= Transient MR abnormalities in patients with brain tumor–related seizures that can incorrectly suggest tumor progression.

Page 4: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Purpose

To present the MR findings of PIPG including diffusion and perfusion imaging.

To differentiate PIPG from true tumor progression and avoid unnecessary interventions.

Page 5: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Case Report

Presentation: August 2013

36 year-old man

Several simple and complex partial seizures with and without generalization.

Page 6: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Case Report

History: February 2010 3 years earlier was diagnosed with left frontal anaplastic astrocytoma (III/IV)

Treatment (completed in 2010):

Surgery Adjuvant radiation (60 Gy in 6 weeks) Concomitant and adjuvant Temozolomide

Page 7: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Case Report

Management: August 2013

Admission MRI Treatment: phenytoin and levetiracetam No recurrence of seizures

Page 8: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Imaging findings

Baseline post-operative MR (Sept. 2012) before presentation:

Left frontal craniotomyPostoperative changesNo diffusion restriction

FLAIR DWI

Page 9: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Imaging findings

T1 post-contrast CBV

Postoperative changesNo concerning enhancementNo increased CBV

Baseline post-operative MR (Sept. 2012) before presentation:

Page 10: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Imaging findings

FLAIR

Left frontal cortical swelling and hyperintensity

MRI Aug. 2013 at presentation:

Page 11: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Imaging findings

Left frontal cortical diffusion restriction

DWI & ADC

MRI Aug. 2013 at presentation:

Page 12: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Imaging findings

T1 post-contrast

T1 pre-contrast

Enhancement

Left frontal cortical/leptomeningeal enhancement

MRI Aug. 2013 at presentation:

Page 13: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Imaging findings

Dynamic Susceptibility Contrast Perfusion

Cortical increased CBV in the left frontal region

MRI Aug. 2013 at presentation:

Page 14: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Imaging findings

FLAIR

Resolution of swelling and signal abnormality

MRI follow up Oct. 2013:

Page 15: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Imaging findings

DWI and ADC

MRI follow up Oct. 2013:

Resolution of diffusion restriction

Page 16: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Imaging findings

Enhancement

MRI follow up Oct. 2013:

T1 pre-contrast

T1 post-contrast

Resolution of leptomeningeal/cortical enhancement

Page 17: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Imaging findings

Dynamic Susceptibility Contrast Perfusion

Resolution of increased CBV in the left frontal region

MRI follow up Oct. 2013:

Page 18: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Summary

Peri-ictal pseudoprogression “PIPG”1

Seizure-associated MR abnormalities in the surgical bed mimicking tumor progression

Rare entity ( <1%) Survivors of glioma who have undergone radiotherapy

Average 10 years after treatment

Page 19: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Summary

Previously described seizure-associated MRI abnormalities: 2-4

Cortical swellingCortical T2/FLAIR hyperintensityCortical diffusion restriction Cortical and/or leptomeningeal enhancement Increased cerebral blood volume (rCBV)

Page 20: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Summary

Mechanism of seizure-associated MRI abnormalities: 2-5

metabolism of seizing neurons Compensatory blood flow: perfusion metabolism > blood flow:

Local tissue hypoxia diffusion restrictionAnaerobic metabolism: lactate & Pco2:

vascular dilatation & leakiness disruption of blood brain barrier and enhancement

Page 21: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Summary

PIPG TUMOR RECURRENCE

Distribution Predominantly cortical Predominantly subcortical

Reversibility Transient & reversible Progressive

Diffusion restriction

Cortical Not limited to the cortexNot a constant feature

Contrast enhancement

Cortical &/or focal leptomeningeal

Predominantly subcorticalLeptomeningeal enhancement

more common diffuse

Perfusion Increased Increased

Page 22: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

References1. Rheims S, Ricard D, van den Bent M et al. Peri-ictal

pseudoprogression in patients with brain tumor. Neuro Oncol. Jul 2011; 13(7): 775–782

2. Rath JJG, Smits M, Ducray F, van den Bent M. J. Increased rCBV in status epilepticus. J Neurol 2012;259:1746–1748

3. Kim JA, Chung JI, Yoon PH et al. Transient MR Signal Changes in Patients with Generalized Tonicoclonic Seizure or Status Epilepticus: Periictal Diffusion-weighted Imaging. AJNR Am J Neuroradiol 2001; 22:1149–1160.

4. Szabo K, Poepel A, Pohlmann-Eden B et al. Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain (2005), 128, 1369–1376.

5. Canasa N, Breiac P, Soares P et al. The electroclinical-imagiological spectrum and long-term outcome of transient periictal MRI abnormalities. Epilepsy Research 2010;91:240—252

Page 23: Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

THANK YOU